Bharat Biotech Concludes Phase 3 trial Of Covaxin Records 77.8% Efficacy Rate

Bharat Biotech Concludes Phase 3 trial Of Covaxin Records 77.8% Efficacy Rate

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | CovidПодробнее

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid

Covaxin Shows 77% Efficacy In Phase 3 Trials, Bharat Biotech Informs Govt Panel, Data Under ReviewПодробнее

Covaxin Shows 77% Efficacy In Phase 3 Trials, Bharat Biotech Informs Govt Panel, Data Under Review

‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial resultsПодробнее

‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results

Bharat Biotech announces successful Phase-3 trial results of Covaxin | Made In India Vaccine | WIONПодробнее

Bharat Biotech announces successful Phase-3 trial results of Covaxin | Made In India Vaccine | WION

Covaxin Shows 77.8% Efficacy In Phase 3 TrialПодробнее

Covaxin Shows 77.8% Efficacy In Phase 3 Trial

Bharat Biotech concludes phase 3 Covaxin trial, claims 77.8% efficacy against COVID 19Подробнее

Bharat Biotech concludes phase 3 Covaxin trial, claims 77.8% efficacy against COVID 19

Bharat Biotech announces Covaxin's efficacy rate after final stage trials | COVID-19 Vaccine | NewsПодробнее

Bharat Biotech announces Covaxin's efficacy rate after final stage trials | COVID-19 Vaccine | News

Bharat Biotech's Covaxin Shows 77.8% Efficacy Rate In Phase 3 TrialПодробнее

Bharat Biotech's Covaxin Shows 77.8% Efficacy Rate In Phase 3 Trial

Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% EfficacyПодробнее

Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy

Covid-19 Vaccine: Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Final Phase 3 DataПодробнее

Covid-19 Vaccine: Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Final Phase 3 Data

Bharat Biotech Covaxin phase III trial is approved by Subject Expert Committee with 77.8% efficacyПодробнее

Bharat Biotech Covaxin phase III trial is approved by Subject Expert Committee with 77.8% efficacy

Covaxin 77.8% effective against Covid, claims Bharat Biotech citing Phase 3 trial dataПодробнее

Covaxin 77.8% effective against Covid, claims Bharat Biotech citing Phase 3 trial data

Covaxin 77.8% Effective In Phase 3 Trial Data: SourcesПодробнее

Covaxin 77.8% Effective In Phase 3 Trial Data: Sources

Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 TrialПодробнее

Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 Trial

Bharat Biotech's Covaxin shows 77.8% efficacy in Phase 3 trial - TV9Подробнее

Bharat Biotech's Covaxin shows 77.8% efficacy in Phase 3 trial - TV9

Bharat Biotech Announces Phase 3 Results of Covaxin, Says It Shows Interim Efficacy of 81%| BreakingПодробнее

Bharat Biotech Announces Phase 3 Results of Covaxin, Says It Shows Interim Efficacy of 81%| Breaking

Phase 3 data shows Covaxin 77 8 percent effective against Covid 19, says LancetПодробнее

Phase 3 data shows Covaxin 77 8 percent effective against Covid 19, says Lancet

Bharat Biotech releases Covaxin Phase-3 trial data, claims 77.8% efficacy - TV9Подробнее

Bharat Biotech releases Covaxin Phase-3 trial data, claims 77.8% efficacy - TV9

Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination | COVID-19 VaccineПодробнее

Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination | COVID-19 Vaccine